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The importance of each of the two interferon (IFN) systems in impeding herpesvirus replication and in
stimulating virus-specific lymphocytes to control an acute systemic infection is not completely understood. To
further our knowledge, pseudorabies virus, attenuated by deletion of the glycoprotein E gene to impair its
neurovirulence and by deletion of the thymidine kinase gene (gE2TK2PRV), was used to infect wild-type
129Sv/Ev and congenic mice with immune system-associated genetic deficiencies. Mice with mature B and T
lymphocytes but lacking either one or both functional receptors for members of each of the two IFN families
were infected with gE2TK2PRV. At 3 and 7 but not 14 days after infection, replicating gE2TK2PRV could be
isolated only from livers or spleens of mice lacking the receptors for both IFN families, and these mice survived
the infection. Therefore, functional IFN receptors were not required to induce a protective immune response
against an acute infection with gE2TK2PRV. Furthermore, PRV-specific antibodies of all immunoglobulin G
isotypes were produced in these mice. Mice without mature B and T lymphocytes and lacking either one or both
functional receptors for members of each of the two IFN families were also infected with gE2TK2PRV. Three
days after infection, replicating virus could be isolated only from mice lacking both mature B and T lympho-
cytes and functional IFN receptors, and these mice were not able to clear the virus. We present evidence that
mice with an intact gamma IFN system but without mature B and T cells were able to prevent systemic
dissemination of gE2TK2PRV.
Pseudorabies virus (PRV) is a member of the subfamily
Alphaherpesvirinae. Besides the pig, considered the reservoir
host of PRV, a variety of other species including mice and rats
can naturally be infected with this virus. After initial repli-
cation at the entry site, the virus gains access to the central
nervous system by transsynaptical cell-to-cell spread and retro-
grade axonal transport within neurons. Using lymphatic or he-
matogenic pathways, PRV may also disseminate systemically
(4, 23, 29). In mice, wild-type PRV strains are associated with
a neurovirulent phenotype. Within days after infection, almost
100% of the animals die. Neurovirulence of PRV is based on
effective neuroinvasiveness and neurotoxicity that has been
associated with the viral glycoproteins E (gE) and I (gI), which
form heterodimers for proper function (2, 17, 42). For efficient
replication in nondividing cells, such as neurons, the viral thy-
midine kinase (TK) is also important. Mice exposed to a gE2
and TK2 double deletion mutant (gE2TK2PRV) control the
infection (2) and react with a potent virus-specific immune
response (18). Therefore, gE2TK2PRV can be used to infect
wild-type or congenic mice with immune system-associated
genetic deficiencies in order to study the contributions of the
innate and specific immune system against PRV infections.
The two interferon (IFN) systems are important compo-
nents of innate immunity and can influence viral replication
either directly by antiviral activity or indirectly by modulation
of the immune response (4, 9, 21). The direct antiviral activity
attributed to alpha/beta IFN (IFN-a/b) and gamma/IFN (IFN-g)
includes the induction of proteins and enzymes that inhibit
virus multiplication by impairing accumulation of virus-specific
mRNA and proteins. Indirect effects of IFNs include the in-
duction of lymphokines, chemokines, and monokines that may
attract and activate macrophages and NK cells (10).
IFNs also have pleiotropic effects on specific lymphocytes.
IFN-g is thought to be a key regulatory cytokine in Th-1-like
immune responses (33, 34, 37). In mice, both IFN-g production
and a Th-1-like immune response appear to be associated with
an immunoglobulin (Ig) isotype switch to virus-specific IgG2a
or IgG3 (7, 37, 38).
With mice congenitally deficient in the IFN-g gene, the ap-
parent redundancy for IFN-g in controlling acute virus infec-
tion was shown for herpes simplex virus type 1 (HSV-1) (47),
murine gammaherpesvirus (31), influenza virus (13), Sendai
virus (24), vesicular stomatitis virus (VSV), and Semliki Forest
virus (33). For an immune response against other viruses, the
IFN-a/b receptor, which binds IFN-a/b, or the IFN-g receptor,
which binds IFN-g, appeared to be required, and the function
of the IFN receptors was nonredundant. This was shown for
lymphocytic choriomeningitis virus (LCMV), vaccinia virus, ec-
tromelia virus, and mouse hepatitis virus (15, 17, 26, 36, 44).
Limited data are available from virus-infected mice with a
deletion of both copies of the IFN-a/b and IFN-g receptor
genes. Infection of these mice with less than 100 infective VSV
or LCMV particles led to overwhelming virus replication and
inadequate immune response (44).
Passive immunization of B-cell-deficient mice with PRV-
specific antibodies (Abs) contributed to protection following
virus challenge (33). PRV-specific cytolytic T cells can be elic-
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ited after virus infection (49), but cytolytic T cells do not ap-
pear to be essential for immunity (3). By contrast, depletion of
CD41 T cells partially abrogates PRV-induced protection (3).
Previously, we have shown that gE2TK2PRV did not lead to
systemic infection in mice with disrupted IFN-g receptor, but
the precise contribution of the innate and specific immune
system to impeding virus spread was not analyzed in detail
(33).
In a first set of experiments described here, mice with ma-
ture B and T cells but lacking either one or both functional
receptors for members of each of the two IFN families were
infected with gE2TK2PRV. The data showed that functional
IFN receptors were not required to induce a protective im-
mune response against an acute gE2TK2PRV infection. In a
second set of experiments, mice without mature B and T cells
(6) and again lacking either one or both functional receptors
for each of the two IFN families were also infected with
gE2TK2PRV. We present evidence that mice with an intact
IFN-g system but without mature B and T cells were able to
prevent systemic dissemination of gE2TK2PRV.
MATERIALS AND METHODS
Mice. Inbred 129Sv/Ev (H-2b) (wt129) mice were used throughout this study.
Congenic mice with gene-targeted disruptions of the IFN-a/b receptor (A129) or
IFN-g receptor (G129) and mice with disrupted IFN-a/b and IFN-g receptors
(AG129) were used (15, 26) (Table 1). Mice with deleted recombination-acti-
vating gene 2 (RAG-2) (6) were crossed with A129 or AG129 mice to obtain
homozygous AR129 (IFN-a/b receptor and RAG-2 deficient) and AGR129
(IFN-a/b and IFN-g receptor and RAG-2 deficient) (17) mice, respectively. The
altered genome of the newly bred mice was analyzed by PCR (6, 26). Homozy-
gous AR129 or AGR129 (19) mice had a normal litter size, and the offspring
remained healthy for more than 1 year under specific-pathogen-free conditions.
All mice were bred and kept under specific-pathogen-free conditions at the
Institut fu¨r Labortierkunde, University of Zu¨rich.
Virus. A PRV strain with deletions of genes encoding gE and TK (18) was
obtained commercially (Intervet, Boxmer, The Netherlands). Aliquots of the
same virus batch were used throughout. Before use, infective virus was deter-
mined as described below (“Virus titration”).
Infection of mice and collection of blood and organs. Mice of both sexes, 6 to
8 weeks of age, were infected intraperitoneally with 5 3 105 50% tissue culture
infective doses of gE2TK2PRV suspended in 200 ml of RPMI medium (Gibco
BRL, Life Technologies, Basel, Switzerland). At 1, 3, and 7 and, in some cases,
14, 21, and 28 days postinfection (dpi) with gE2TK2PRV, animals were sacri-
ficed. Blood was drawn and allowed to clot to obtain serum. Livers, lungs,
kidneys, brains, one-fourth of the spleens, and clotted blood cells were snap
frozen in liquid nitrogen and kept at 280°C. The rest of the spleen was taken and
used for splenocyte restimulation experiments (see below).
Virus titration. The snap-frozen organs and the blood cell pellets were allowed
to thaw, and the organs were homogenized by mortar, pestle, and sterile sand.
Tenfold dilutions starting at 1022 of the centrifugation-clarified supernatant
were titrated on MDBK cells as described elsewhere (25). Plaques were counted
64 h after seeding, and virus titers were expressed as log10 PFU per organ or cell
sample. The detection limit of gE2TK2PRV was 102 PFU/organ or cell sample.
Splenocyte restimulation assay. For the analysis of the cytokine production in
vitro, erythrocyte-depleted splenocytes (1.5 3 106 cells/ml) were cultured in
24-well plates (Nunc, Breda, The Netherlands) as described before (32). Super-
natants of the cultures were harvested 48 h after cell seeding and stored at
220°C.
Analysis of cytokine levels. For the analysis of in vivo cytokine production of
interleukin-1b (IL-1b), IFN-g, IL-2, IL-4, IL-6, IL-10, and IL-12-p40, sera were
analyzed at 1, 3, and 7 dpi with a commercial enzyme-linked immunosorbent
assay (ELISA) kit (R&D Systems, Minneapolis, Minn.). Similarly, cytokine con-
centrations in supernatants from splenocyte cultures were determined with the
same system.
Determination of PRV-specific serum Ab titers. Titers of PRV-specific total Ig
and of PRV-specific IgG isotypes (IgG1, IgG2a, IgG2b, and IgG3) in serum were
determined by ELISA essentially as previously described (32). Briefly, 96-well
flat-bottomed plates (Nunc) were coated with 100 ml of predetermined inacti-
vated PRV particles as antigen suspended in NaHCO3 (0.05 M, pH 9.6) and
incubated overnight at 4°C. Subsequently, plates were frozen at 220°C for at
least 24 h or until use. After thawing, the plates were washed with tap water. The
serum samples were diluted twofold starting at 1/16 in phosphate-buffered saline
(0.04 M), 0.1% Tween 20, and 1% bovine serum albumin (Sigma Chemical Co.,
St. Louis, Mo.) and incubated for 1 h at 37°C. After incubation, the plates were
washed again with tap water. Ig (total)- and IgG isotype-specific Abs directly
coupled to horseradish peroxidase (Southern Biotechnology Associates, Inc.,
Birmingham, Ala.) appropriately diluted in the same buffer as the sera were
added for 30 min at 37°C. The IgG isotype specificity of the horseradish perox-
idase-coupled Ab was verified as described elsewhere (5). After being washed
with tap water, the substrate was allowed to react for 30 min at room tempera-
ture. The reaction was stopped with 2 M sulfuric acid and read at 450 nm. The
Ig titers of the sera were defined as the reciprocal of the highest dilution with an
absorbency twice that of the background.
RESULTS
gE2TK2PRV is systemically disseminated in AG129 mice
but not in wt129, A129, or G129 mice. Groups of three to
four mice (Table 1) were infected with gE2TK2PRV and
monitored clinically. To analyze systemic virus dissemina-
tion, gE2TK2PRV titers were determined in liver and spleen
tissue at 3, 7, and, in some cases, 14 or 28 dpi. As expected
from previous experiments, no virus could be detected at any
time point in liver or spleen tissue from wt129 mice or G129
mice (33) or A129 mice (Table 2).
gE2TK2PRV-inoculated AG129 mice appeared clinically
healthy and survived infections for up to 4 weeks. However, in
this mouse strain virus could be recovered from spleen and
liver tissue (Table 2) at 3 and 7 dpi. Two weeks after virus
infection, no virus could be isolated from any organ of the 14
AG129 mice tested. Therefore, neither of the two IFN systems
appeared to be required to clear systemic gE2TK2PRV.
RAG-2-deficient and AR129 mice but not AGR129 mice con-
trol systemic infection of gE2TK2PRV. To analyze gE2TK2
PRV replication in the absence of mature major histocompat-
ibility complex (MHC)-restricted T cells and functional B cells,
RAG-2-deficient mice were inoculated with gE2TK2PRV,
and systemic virus dissemination was analyzed as described
TABLE 1. Overview of mouse strains used
Mouse strain IFN-a/b system IFN-g system Mature B and T cells
wt129a Functional Functional Present
A129 Nonfunctional Functional Present
G129 Functional Nonfunctional Present
AG129 Nonfunctional Nonfunctional Present
RAG-2 deficientb Functional Functional Absent
AR129 Nonfunctional Functional Absent
AGR129 Nonfunctional Nonfunctional Absent
a Mice (129Sv/Ev; H-2b) of the same MHC haplotype were used.
b Mice with both copies of RAG-2 deleted are unable to produce mature
specific B and T cells (6).
TABLE 2. Determination of gE2TK2PRV titers in
liver and spleen tissue
Mouse
strain(s) dpi
a
Virus titer in tissue:
Liver Spleen
wt129, A129, G129,
RAG-2
3 ,102 ,102
7 ,102 ,102
AG129 3 2.4 3 102 6 2.1 3 102 2 3 102 6 1.9 3 102b
7 1.6 3 102 6 0.8 3 102c 1.5 3 102 6 1.1 3 102b
AR129 3 ,102 ,102
7 ,102 ,102
AGR129 3 4 3 102 6 2 3 102 3.2 3 102 6 1.5 3 102
7 5.3 3 106 6 2.4 3 106 2.4 3 104 6 2.1 3 104
a At 3 and 7 days after infection with gE2TK2PRV, organs were analyzed for
the presence of virus. Values are means from two groups of three mice.
b Four of six animals had detectable amounts of virus.
c Five of six animals had detectable amounts of virus.
VOL. 73, 1999 PRV INFECTION IN INTERFERON- AND IMMUNODEFICIENT MICE 4749
above (Tables 1 and 2). No virus could be isolated from livers
or spleens of RAG-2-deficient mice at 3, 7, or 28 dpi. Thus, in
the absence of specific lymphocytes, the innate immune system
was able to prevent systemic spread of gE2TK2PRV.
To test the contribution of the IFN systems to the control
of virus replication in RAG-2-deficient mice, AR129 and
AGR129 mice (Table 1) were infected with gE2TK2PRV and
monitored clinically. AR129 mice remained healthy through-
out the analyzed period of 4 weeks after infection. By contrast,
AGR129 mice were moribund at 7 dpi and were euthanized.
Virus titers in liver and spleen tissue were analyzed at 3, 7,
and, in some cases, 14 and 28 dpi (Table 2). No virus could be
detected in organs of AR129 mice at any time point. By con-
trast, at 3 dpi, 102 to 103 PFU of gE2TK2PRV could be
isolated from livers and spleens of infected AGR129 mice.
Virus titer in the AGR129 mice reached 106 to 107 PFU of
gE2TK2PRV/liver or spleen at 7 dpi. About one-third of the
animals were viremic at this time point, and virus could be
isolated from whole blood as well as kidney, lung, and brain
(data not shown). Histological evidence for tissue damage
found in liver, pancreas, and lung tissue of AGR129 mice was
further indicative of the presence of virus in these organs (data
not shown). Therefore, the absence of functional receptors for
IFN-a/b and IFN-g in combination with the lack of mature T
and B cells led to uncontrolled systemic virus replication in
AGR129 mice. By contrast, the functional IFN-g system in
AR129 mice was sufficient to prevent systemic dissemination of
gE2TK2PRV.
Determination of cytokines present in serum of gE2TK2
PRV-infected mice. To analyze the early immune response
against gE2TK2PRV infections ex vivo, the amounts of the
proinflammatory cytokines IL-6, IL-1b, and tumor necrosis
factor alpha (TNF-a) were analyzed in the sera at various time
points after infection of mice. In three separate infection ex-
periments, significant concentrations of IL-6 were detected in
the sera from 10 of a total of 12 AR129 mice after 24 h, in all
AG129 mice at 3 dpi, and in all AGR129 mice at 7 dpi (Fig. 1).
Mock-infected animals had no detectable serum IL-6 (data not
shown). It is possible that IFN-g produced locally by AR129
mice with a functional IFN-g receptor but not in AGR129 mice
without a functional IFN receptor caused a rapid induction of
acute-phase proteins including IL-6 (1, 28, 41).
IL-1b (75 6 40 pg/ml) was found only in sera from AGR129
mice at 7 dpi. Low but significant amounts of TNF-a were
found at 7 dpi in the sera from three of six AGR129 mice
analyzed (data not shown).
Among the lymphocyte-associated cytokines, IL-2, IL-4, IL-
10, IFN-g, and IL-12-p40 were analyzed. The latter two cyto-
kines were detected in the sera of AG129 and AGR129 mice
but not in those of the other mouse strains investigated. In
AG129 mice, the serum IFN-g concentration was maximal
(12 ng/ml) at 3 dpi and declined thereafter. In AGR129 mice,
IFN-g was first detected at 3 dpi and reached more than 25 ng/
ml of serum at 7 dpi (see Fig. 2). IL-12-p40 (785 6 250 pg/
ml) was found in AGR129 mice at 7 dpi. None of the cyto-
kines analyzed was detected in mock-infected animals (data
not shown). Thus, a rough correlation was found between
viral titers in organs and cytokine levels in sera. With low
amounts of virus present in organs, only IL-6 and IFN-g were
detected. With increasing viral titers, additional cytokines as
well as more abundant quantities of the cytokines were detect-
ed. (Fig. 1 and 2; Table 2). Importantly, cytokines were de-
tected early (day 1) in AR129 mice with an intact IFN-g system
but relatively late (days 3 to 7) in AG129 and AGR129 mice
without functional IFN receptors.
Cytokine production of in vitro-restimulated spleen cells
analyzed at 3 and 7 days after gE2TK2PRV infection. In order
to specifically analyze the cytokines secreted by splenocytes
from the different mice, in vitro restimulation assays were
performed at various time points after infection (Table 2).
Around 800 pg of IFN-g per ml was detected in spleen cell
cultures from wt129 mice set up at 3 dpi. Significantly more
IFN-g was present in cultures of splenocytes from A129, G129,
or AG129 mice analyzed at the same time point. Seven days
after infection, 7 ng of IFN-g per ml was produced by spleen
cell cultures of wt129 mice. At this time point, similar amounts
of IFN-g ranging from 3 to 6 ng/ml were produced by spleen
cells of A129 and AG129 mice but 10 times less was produced
by spleen cells from G129 mice. In splenocyte cultures of
AR129 or AGR129 mice devoid of specific lymphocytes, no
significant amounts of IFN-g were detected at any time point
analyzed, even though large amounts of IFN-g were detected
in sera of AGR129 mice. Hence, comparable high amounts of
IFN-g were produced from splenocytes of gE2TK2PRV-in-
fected wt129, A129, G129, and AG129 mice at day 3 and day
7. This indicates that the production of IFN-g did not depend
on intact receptors for IFN (Table 3).
In contrast to the production of IFN-g, minimal amounts of
IL-4 were found in the same culture supernatants at day 3
(Table 3). In general, somewhat more IL-4 was found at day 7.
The IFN-g/IL-4 ratio calculated was at least 10 but was as high
FIG. 1. Serum IL-6 levels in AR129, AG129, and AGR129 mice (left, mid-
dle, and right bars, respectively) infected with gE2TK2PRV. Serum IL-6 level
was determined by ELISA at 1, 3, and 7 dpi. Values are means 1 standard
deviations (error bars) from either 6 or 12 mice. Asterisks indicate statistical
significance of values from different time points.
FIG. 2. Serum IFN-g levels in AG129 and AGR129 mice infected with
gE2TK2PRV. Serum IFN-g level was determined by ELISA at 1, 3, and 7 dpi.
Values are means 1 standard deviations (error bars) from either three or 6 mice.
Asterisks indicate statistical significance of values from different time points.
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as 300 at day 3. Therefore, the disruption of one or both IFN
receptor genes did not alter the high IFN-g/IL-4 ratio.
Other cytokines were found in spleen cell cultures of some
mouse strains but were present in only low amounts. TNF-a
was detected in similar levels in wt129, A129, G129, and
AG129 mice at day 3 (90 to 110 pg/ml) and day 7 (110 to 160
pg/ml). In general, less than 100 pg of IL-12-p40 per ml was
detected in any cell culture analyzed.
The lymphocyte-associated cytokines IL-2 (97.3 6 25.4 pg/
ml) and IL-10 (274.8 6 127 pg/ml) were produced in cell
cultures set up from spleens of 12 wt129 mice at 7 dpi. With
spleen cells from the other mouse strains, only low amounts of
IL-2 and IL-10 were occasionally seen (data not shown). Thus,
among the cytokines analyzed, IFN-g was the main cytokine
secreted by splenocytes at 3 and 7 dpi, independent of the
presence or absence of the two IFN receptors.
The production of PRV-specific IgG2a is independent of
IFN receptors. Sera of mice taken at 3, 7, 14, or 28 dpi were
analyzed for PRV-specific Ab by ELISA (Fig. 3). At day 3,
little if any PRV-specific Ab was detected in any mouse strain
analyzed. At day 7, significantly more total IgG Ab against
PRV was produced by wt129 mice than by G129 mice. By con-
trast, AG129 mice produced more IgG Ab against the antigen
than did wt129 mice. Only half of the wt129, A129, and G129
mice had detectable IgG1 Ab against PRV, whereas all AG129
mice had high levels of IgG1 against PRV with a mean titer of
1/2,000. At day 7, wt129 mice as well as all IFN-receptor-de-
ficient mice with mature B and T cells responded with IgG2a
Ab specific to PRV. wt129 mice produced significantly more
IgG2a Ab against PRV than did G129 mice. This positive reg-
ulatory role for IFN-g in Ab formation has been noted earlier
(33). AG129 mice produced more IgG2a Ab against the PRV
antigen than did wt129 mice (Fig. 3), possibly as a result of the
higher antigenic load. Little if any PRV-specific Ab of the
IgG2b or IgG3 subclass was detected in any serum analyzed at
7 dpi.
At 14 or 28 dpi, all mice with functional RAG (5) produced
maximal PRV-specific Ab titers of all IgG isotypes with a
preference for IgG2a and IgG2b as previously reported (33).
In AG129 mice, the titers of IgG1 and IgG2a Abs remained
similar (Fig. 4). Sera from AR129 or AGR129 mice remained
negative in all ELISAs as expected from mice with deletion of
RAG-2 (5). Thus, the onset of Ab production between days 3
and 7 and the spectrum of Ig isotype patterns produced were
not fundamentally influenced by the absence of either IFN
system, although differences in antigen load should be consid-
ered.
DISCUSSION
Components of both the innate and specific immune systems
of mice were analyzed for their contribution to prevention of
systemic dissemination of a highly attenuated pseudorabies
virus, gE2TK2PRV.
AR129 mice have a functional IFN-g system but lack mature
MHC-restricted T and mature B lymphocytes because of a
deletion of both copies of RAG-2 (6) (Table 1). After infection
of AR129 mice with gE2TK2PRV, no virus could be isolated
from any organ of these animals (Table 2). In the absence of
PRV-specific lymphocytes, the control of virus replication in
these mice could either be due to a direct antiviral effect of the
IFN-g system or be mediated indirectly by the innate immune
system (14, 30, 42). IFN-g was not detected in serum of gE2
TK2PRV-infected AR129 mice, but we cannot exclude the
possibility that this cytokine was produced locally in concen-
trations too small to be detected systemically. It is possible that
IFN-g and the acute-phase protein IL-6 induced rapidly within
1 dpi with gE2TK2PRV were able to control virus replication
directly (Fig. 1). This has also been shown for other viral
infections (1, 20, 28, 48). Alternatively, protection may have
been mediated indirectly by cells of the innate immune system
such as NK cells. NK cells have been shown to be effective in
the defense against HSV-1 or murine cytomegalovirus. How-
FIG. 3. PRV-specific Ab titers of mice infected with gE2TK2PRV at 7 dpi.
Titers of total Ig, IgG1, and IgG2a (left, middle, and right bars of each strain,
respectively) specific to PRV of the mouse strains indicated were determined by
ELISA. Values are means 1 standard deviations (error bars) from either five or
nine mice. Asterisks indicate statistical significance of values from different
mouse strains compared to wt129.
TABLE 3. Determination of IFN-g and IL-4 levels in supernatants of in vitro-restimulated splenocytesa
Mouse
strain
IFN-g IL-4 IFN-g/IL-4 ratio for
gE2TK2PRV
Mock
(day 7)
gE2TK2PRV Mock
(day 7)
gE2TK2PRV
Day 3 Day 7 Day 3 Day 7 Day 3 Day 7
wt129 ,10 835 6 132 6,926 6 904 ,10 ,10 101 6 7 NC 68.5
A129 15 6 13 4,754 6 810 6,293 6 459 78 6 62 16.3 6 2.5 59.5 297 107.6
G129 60 6 16 3,825 6 277 691 6 284 70 6 68 11.7 6 3.7 54 6 31 326 12.7
AG129 33 6 18 5,678 6 2,800 2,920 6 757 12.7 6 7.5 ,10 49 6 28 NC 59.6
RAG-2 ,10 ,10 ND ,10 ,10 NC NC NC
AR129 ,10 ,10 ND ,10 ,10 NC NC NC
AGR129 ,10 ,10 ND ,10 ,10 NC NC NC
a Spleen cell restimulation assays were performed 3 and 7 days after infection with gE2TK2PRV. IFN-g and IL-4 levels (picograms per milliliter) were determined
by ELISA 48 h after in vitro restimulation. Values are means from spleen cells of three mice each either infected with gE2TK2PRV or mock infected. NC, values could
not be calculated; ND, not determined.
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ever, the following considerations argue against a massive ac-
tivation of NK cells in AR129 mice infected with gE2TK2
PRV. NK cell activity was described as being associated with
early production of serum IL-1, IL-6, IL-12, IFN-g, and TNF-a
(28, 30, 43). With the exception of IL-6, no significant cytokine
production was found in serum of AR129 mice, and none was
detected in splenocyte cultures set up at 3 dpi (Table 3). Thus,
the amount of gE2TK2PRV used in the present infection
experiments may have failed to trigger a detectable NK cell
activation in spleens of AR129 mice. Although NK cell activity
in these mice has not been specifically tested after PRV infec-
tion, NK cells in AR129 mice are functional, as previously
shown by their capacity for eliminating tumors (11). Therefore,
our data suggest that the control of gE2TK2PRV replication
by the IFN-g system was due either to its direct local antiviral
effect or, indirectly, to the induction of proinflammatory cyto-
kines such as IL-6 or a combination of both (20). Preliminary
experiments indicate that the IFN-a/b system (GR129 mice)
was equally capable of preventing systemic dissemination of
gE2TK2PRV (40).
In contrast to AR129 mice, AGR129 mice lack both IFN
receptors and mature B and T cells. AGR129 mice appeared
unable to control dissemination of gE2TK2PRV (Tables 1 and
2). High levels of IFN-g were found in the sera of gE2TK2
PRV-infected AGR129 mice at days 3 and 7, and some IL-6,
IL-1b, IL-12-p40, and TNF-a were found at day 7 pi. It was
shown that TNF-a and TNF-b could both directly inhibit virus
replication and act in synergy with IFN-g (46). However, our
data indicate that in the absence of functional IFN receptors,
TNF-a alone did not have a detectable antiviral effect in
AGR129 mice. As suggested by others, the proinflammatory
cytokines produced late after infection had no apparent anti-
viral effect when extensive virus replication had occurred (26,
28). Moreover, IFN molecules in mice devoid of functional
IFN-a/b and IFN-g receptors have no biological effect (16, 26).
The titers of gE2TK2PRV in spleens or livers from AGR129
mice without and AG129 mice with mature B and T cells were
similar at 3 dpi with gE2TK2PRV (Table 2). Interestingly,
significant amounts of IL-6 in these mice were detected only at
3 dpi. By contrast, in AR129 mice with an intact IFN-g system,
high levels of IL-6 and possibly other acute-phase proteins
were present in sera at 1 dpi. Importantly, the presence of
these molecules early after infection was associated with the
control of PRV replication (Table 2). Therefore, the inability
of mice devoid of functional IFN receptors to rapidly induce
acute-phase proteins or other components of innate immunity
could not be compensated for by mature B and T cells or their
products within the first 3 days after infection.
By 3 dpi, the first virus-specific Ab could be detected in some
AG129 mice. By 7 dpi, high titers of PRV-specific IgG1 and
IgG2a were present in all AG129 mice, reaching maximal titers
of virus-specific Abs of all Ig isotypes at 14 dpi (Fig. 4). Sera
from AG129 mice had virus-neutralizing activity as determined
by in vitro plaque inhibition assays (data not shown).
By 7 dpi, marginal virus titers were still detected in periph-
eral organs of AG129 mice, whereas in AGR129 mice the viral
replication reached titers of 106 PFU per organ, and these mice
had to be euthanized at this time point. By contrast, AG129
mice remained healthy, and no virus was detected in any organ
analyzed by virological and histological methods 14 dpi (data
not shown). We conclude that specific immune cells devoid of
IFN receptors in AG129 mice are capable of clearing replicat-
ing gE2TK2PRV and that the Ab produced by these mice may
partly be responsible for the clearance of replicating virus.
Protection against virulent PRV by prior administration of
serum from hyperimmune animals to G129 mice has been
demonstrated elsewhere (33) and was also shown for HSV-2
(27). While the two IFN systems can possibly compensate for
each other during acute PRV infections, their contribution in
chronic viral infections still needs to be addressed (12, 22, 45).
wt129 mice survived infections with 2 3 106 PFU of VSV,
whereas A129 or AG129 mice infected with the same virus
were unable to mount a protective immune response, even
when exposed to less than 100 infective particles (44). Further-
more, LCMV was capable of replicating persistently and un-
restrictedly in both A129 and AG129 mice, whereas wt129
mice could clear the virus. Thus, the outcomes of VSV and
LCMV infections in A129 or AG129 mice are markedly dif-
ferent from the outcome of an inoculation with the highly
attenuated gE2TK2PRV. One explanation appears to be the
higher efficiency with which VSV or LCMV can replicate in the
IFN-receptor-deficient host compared to gE2TK2PRV. When
AG129 mice were infected with 106 PFU of VSV, the virus
titers were 106 PFU in spleens or livers 4 dpi (26). With a
similar infective dose of the gE2TK2PRV in AGR129 or
AG129 mice, only 102 to 103 PFU of gE2TK2PRV per organ
was found within the same time frame. Although AGR129 or
AG129 mice appeared unable to control gE2TK2PRV repli-
cation before 3 dpi, specific lymphocytes induced and Abs
produced in AG129 mice were capable of inhibiting virus rep-
lication between days 3 and 14. After infection of A129 mice
with VSV, the virus replication was overwhelming and the Ab
production was inadequate to raise efficient antiviral protec-
tion. By contrast, antiviral protection by VSV-specific Ab given
before systemic virus infection of A129 mice could be shown
(39).
In mice, Ig isotype switch is an important readout to identify
the type of immune response induced. Interestingly, a similar
Ig isotype profile of PRV-specific Ab was produced in all mice
with mature B and T cells analyzed, including AG129 mice.
Yet, G129 mice showed impaired humoral responses as ob-
served previously (33). Furthermore, AG129 mice infected
with HSV-1 were able to clear replicating HSV-1 and pro-
duced virus-specific IgG2a (40). This is in contrast to LCMV-
infected AG129 mice that were unable to switch to IgG2a, the
dominant Ig isotype present in wt129 littermates after LCMV
infection (46).
FIG. 4. PRV-specific Ab titers of AG129 mice infected with gE2TK2PRV at
14 dpi. Titers of total Ig, IgG1, IgG2a, IgG2b, and IgG3 specific to PRV in the
sera were determined by ELISA. Values are means 1 standard deviations (error
bars) from three mice.
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gE2TK2PRV-infected AR129 or GR129 mice (40) were
able to control systemic spread of the virus, and a potent
humoral immune response was induced in mice with intact
RAG. Attenuated but replication-competent live virus, as used
in the present experiments, is far more effective in inducing an
immune response than are inactivated vaccines, indicating a
link between some elements of virus replication and immuno-
genicity (33, 35). Herpesvirus replication can directly induce a
plethora of gene products associated with immune system en-
hancement including IFN or IFN regulatory molecules, cyto-
kines, chemokines, and their receptors (48). On the other hand,
IFNs are potent amplifiers of acute-phase proteins and can
regulate cells involved in early as well as in late immune re-
sponses (1, 8, 28). Each of the two IFN systems appears capa-
ble of controlling the spread of gE2TK2PRV, indicating the
potency and need for early upregulation of proinflammatory
signals to confine PRV replication. Indeed, the absence of the
IFN receptors in AGR129 mice has devastating effects. In the
absence of specific immunity, cytokines may eventually accu-
mulate to high levels but they appear ineffective in preventing
systemic dissemination of an apparently unrestricted replica-
tion of PRV.
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